HDAC9 and fibrosis: Although it was previously mentioned that class II HDAC inhibitors do not exhibit antifibrotic effects in TAA fibrosis model, a study carried out by Mannaerts and colleagues demonstrated that class II HDAC inhibition blocked mouse primary HSCs activation [79].